| r‑TAR/rh-TAR (n = 13) | ||||
|---|---|---|---|---|
| Range | p Wert | |||
| Krankenhausaufenthaltsdauer in Tagen (MW [SA]) | 4,7 | – | (±2,9) | – |
| VAS am 1. postoperativen Tag (MW [SA]) | 3,7 | – | (±2,4) | – |
| Drainagenmenge (ml) | ||||
| Drainage #1 (subphrenisch) (MW, Range [SA]) | 246,3 | 40–560 | (±171,5) | p = 0,181 |
| Drainage #2 (Hypogastrium) (MW, Range [SA]) | 145,6 | 20–410 | (±150,1) | |
| Dauer der Drainagen in situ (Tage) | ||||
| Drainage #1 (subphrenisch) (MW, Range [SA]) | 3,1 | 1–5 | (±1,2) | p = 0,292 |
| Drainage #2 (Hypogastrium) (MW, Range [SA]) | 2,5 | 1–5 | (±1,0) | |
| Unerwünschte Ereignisse innerhalb 6 Wochen | ||||
| Wundereignisse (SSO) (n [%]) | 5 | – | (38,4) | – |
| Serom (n [%]) [13] | 2 | – | (15,3) | – |
| – Grad I | – | – | – | – |
| – Grad II | 1 | – | (7,6) | – |
| – Grad III | 1 | – | (7,6) | – |
| – Grad IV | – | – | – | – |
| Hämatom (n [%]) | 3 | – | (23,0) | – |
| Wundinfektion (n [%]) | – | – | – | – |
| Ungeplante Wiedervorstellung bei Schmerzen (n [%]) | – | – | – | – |
| Verzögertes Einsetzen der Darmpassage (n [%]) | – | – | – | – |
| Thrombembolisches Ereignis (n [%]) | – | – | – | – |
| Clavien-Dindo (n [%]) [14] | 4 | – | (30,7) | – |
| Grad I | 4 | – | – | – |
| Grad II | – | – | – | – |
| Grad IIIa | 1 | – | – | – |
| Grad IIIb | 2 | – | – | – |
| Grad IV | – | – | – | – |
| Nachuntersuchung nach 6 Wochen (n [%]) | ||||
| Erfolgt | 13 | – | (100,0) | – |
| Rezidiv | – | – | (0,0) | – |
| Bauchdeckenschmerzen | – | – | (0,0) | – |
| Serom | 1 | – | (7,6) | – |
| Hämatom | 1 | – | (7,6) | – |
MW Mittelwert, Range Variationsbreite, r‑TAR/rh-TAR robotischer „transversus abdominis release“/Hybridvariante, SA Standardabweichung, SSO „surgical site occurrence“, VAS visuelle Analogskala für Schmerzeinschätzung